Diabetes
Weight-loss drugs show early promise for alcohol and other addictions, review finds
Heather Vogel AI에 의해 생성된 이미지 사실 확인됨
Medications such as semaglutide (marketed as Ozempic/Wegovy) could aid treatment of alcohol and other substance use disorders, according to a peer‑reviewed review in the Journal of the Endocrine Society. Early animal and human data suggest these GLP‑1 receptor agonists act on brain reward circuits; lead author Lorenzo Leggio urged caution, saying, “Early research in both animals and humans suggests that these treatments may help reduce alcohol and other substance use.”
New Advances in Diabetes Management Technologies
Recent developments in diabetes care include smarter insulin delivery systems and an AI-paired artificial pancreas, highlighted on September 11, 2025.
Calorie-reduced Mediterranean diet lowers diabetes risk by 31 percent
AI에 의해 보고됨
A large Spanish clinical trial has shown that a calorie-restricted Mediterranean diet combined with exercise and counseling reduces the risk of type 2 diabetes by 31 percent in at-risk adults. The PREDIMED-Plus study followed nearly 5,000 participants over six years, demonstrating significant weight loss and waist reduction. Researchers highlight this approach as a practical, scalable strategy to combat the global diabetes epidemic.
Study finds GLP-1 drugs may slow alcohol effects
Researchers at Virginia Tech's Fralin Biomedical Research Institute have published a study suggesting that GLP-1 medications, such as Ozempic and Wegovy, could help reduce alcohol consumption by slowing its absorption into the bloodstream. Participants on these drugs reported feeling less intoxicated after drinking the same amount of alcohol as those not taking them. The findings, from a pilot study involving 20 adults, point to a potential new approach distinct from traditional treatments.
Candice Sehoma's activism from toilets to TB drugs
Candice Andisiwe Sehoma, a young South African activist with Médecins Sans Frontières, has dedicated her career to improving access to affordable medicines and basic sanitation. From building flush toilets in her Alexandra community to challenging pharmaceutical giants on tuberculosis and diabetes treatments, her work highlights ongoing healthcare inequities. Her efforts have secured significant price reductions for life-saving drugs in South Africa.
WHO Updates Diabetes Essential Medicines
AI에 의해 보고됨 사실 확인됨
The World Health Organization has updated its essential medicines list to include key diabetes treatments, improving access to innovative care. Advancements also feature AI-paired devices and smarter insulin systems for better management. These tools aim to enhance monitoring and delay onset in at-risk groups.